• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    More On GSK.L

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    GlaxoSmithKline plc (GSK.L)

    -LSE
    1,467.00 Down 25.50(1.71%) Jan 30, 11:50AM EST
    Add to Portfolio
    Prev Close:1,492.50
    Open:1,490.00
    Bid:1,466.50
    Ask:1,467.50
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:1,467.00 - 1,493.00
    52wk Range:1,200.67 - 1,709.00
    Volume:11,242,717
    Avg Vol (3m):8,159,250
    Market Cap:70.53B
    P/E (ttm):1,711.79
    EPS (ttm):0.86
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in GBp.

    Key Statistics

    Forward P/E (1 yr):0.16
    P/S (ttm):302.45
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :93.87
    Quarterly EPS Est (Dec-14) :25.94
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):5.18

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, such as vaccines, over-the-counter medicines, and health-related consumer products worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback